Published in
American Society of Clinical Oncology, JCO Precision Oncology, 7, 2023
DOI: 10.1200/po.23.00255
Links
Tools
Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E-Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy
Journal article published in 2023 by
Roberto Moretto,
Marco Maria Germani 
,
Javier Ros ,
Francesca Daniel,
Filippo Ghelardi,
Guglielmo Vetere ,
Mirella Giordano,
Rodrigo De Almeida Toledo ,
Francesca Bergamo ,
Giovanni Randon,
Elena Elez,
Sara Lonardi ,
Filippo Pietrantonio ,
Paola Vignali,
Daniele Rossini
and other authors.
,
Javier Ros ,
Francesca Daniel,
Filippo Ghelardi,
Guglielmo Vetere ,
Mirella Giordano,
Rodrigo De Almeida Toledo ,
Francesca Bergamo ,
Giovanni Randon,
Elena Elez,
Sara Lonardi ,
Filippo Pietrantonio ,
Paola Vignali,
Daniele Rossini
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
2nd-line target therapy outperforms chemotherapy in patients with BRAFV600E-mut mCRC regardless of RNF43 status.